Annual ROE
-24.08%
-4.74%-24.51%
December 31, 2023
Summary
- As of February 7, 2025, DSGN annual return on equity is -24.08%, with the most recent change of -4.74% (-24.51%) on December 31, 2023.
- During the last 3 years, DSGN annual ROE has fallen by -97.26% (-132.91%).
- DSGN annual ROE is now -132.91% below its all-time high of 73.18%, reached on December 31, 2020.
Performance
DSGN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-18.01%
+0.47%+2.54%
September 30, 2024
Summary
- As of February 7, 2025, DSGN quarterly return on equity is -18.01%, with the most recent change of +0.47% (+2.54%) on September 30, 2024.
- Over the past year, DSGN quarterly ROE has increased by +0.47% (+2.54%).
- DSGN quarterly ROE is now -124.61% below its all-time high of 73.18%, reached on December 31, 2020.
Performance
DSGN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DSGN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.5% | +2.5% |
| 3 y3 years | -132.9% | -89.2% |
| 5 y5 years | -142.8% | - |
DSGN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -158.9% | at low | -100.6% | +24.0% |
| 5 y | 5-year | -132.9% | at low | -124.6% | +24.0% |
| alltime | all time | -132.9% | at low | -124.6% | +24.0% |
Design Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -18.01%(-2.5%) |
| Jun 2024 | - | -18.48%(-11.1%) |
| Mar 2024 | - | -20.79%(-8.9%) |
| Dec 2023 | -24.08%(+24.5%) | -22.81%(-3.7%) |
| Sep 2023 | - | -23.69%(+1.9%) |
| Jun 2023 | - | -23.25%(+12.2%) |
| Mar 2023 | - | -20.73%(+14.3%) |
| Dec 2022 | -19.34% | -18.14%(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -15.73%(+16.5%) |
| Jun 2022 | - | -13.50%(+20.5%) |
| Mar 2022 | - | -11.20%(+24.7%) |
| Dec 2021 | -9.30%(-112.7%) | -8.98%(-5.7%) |
| Sep 2021 | - | -9.52%(+31.1%) |
| Jun 2021 | - | -7.26%(+9.7%) |
| Mar 2021 | - | -6.62%(-109.0%) |
| Dec 2020 | 73.18%(+30.2%) | 73.18% |
| Dec 2019 | 56.21% | - |
FAQ
- What is Design Therapeutics annual return on equity?
- What is the all time high annual ROE for Design Therapeutics?
- What is Design Therapeutics annual ROE year-on-year change?
- What is Design Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Design Therapeutics?
- What is Design Therapeutics quarterly ROE year-on-year change?
What is Design Therapeutics annual return on equity?
The current annual ROE of DSGN is -24.08%
What is the all time high annual ROE for Design Therapeutics?
Design Therapeutics all-time high annual return on equity is 73.18%
What is Design Therapeutics annual ROE year-on-year change?
Over the past year, DSGN annual return on equity has changed by -4.74% (-24.51%)
What is Design Therapeutics quarterly return on equity?
The current quarterly ROE of DSGN is -18.01%
What is the all time high quarterly ROE for Design Therapeutics?
Design Therapeutics all-time high quarterly return on equity is 73.18%
What is Design Therapeutics quarterly ROE year-on-year change?
Over the past year, DSGN quarterly return on equity has changed by +0.47% (+2.54%)